Healthcare Industry News:  Endeavor 

Biopharmaceuticals Personnel

 News Release - March 11, 2008

Pfizer's Waxman to Leave

Remains Outside Counsel Through Transition Period

NEW YORK--(HSMN NewsFeed)--Pfizer said today that Senior Vice President and General Counsel Allen Waxman is leaving the company for personal reasons. Mr. Waxman will remain outside counsel to Pfizer through a transition period.

Pfizer said David Reid, currently Senior Vice President and Managing Director, will assume Mr. Waxman’s responsibilities on an interim basis while the company conducts a search for a permanent successor.

“Allen and his team have been strong advocates for Pfizer, securing a number of important legal decisions that are significant for our business and our future,” said Jeff Kindler, Chairman and Chief Executive Officer. “Allen has provided valuable counsel not only on legal matters but on our overall business strategy and the issues facing Pfizer in its operating environment. He has made many contributions to our company. We thank him for those contributions and wish him well in his future Endeavors.”


Source: Pfizer

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.



RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!